239 related articles for article (PubMed ID: 22287839)
1. Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly(ethylene glycol)-poly(ɛ-caprolactone) nanoparticles.
Liu Q; Li RT; Qian HQ; Yang M; Zhu ZS; Wu W; Qian XP; Yu LX; Jiang XQ; Liu BR
Int J Nanomedicine; 2012; 7():281-95. PubMed ID: 22287839
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
[TBL] [Abstract][Full Text] [Related]
3. Intelligently targeted drug delivery and enhanced antitumor effect by gelatinase-responsive nanoparticles.
Li R; Wu W; Liu Q; Wu P; Xie L; Zhu Z; Yang M; Qian X; Ding Y; Yu L; Jiang X; Guan W; Liu B
PLoS One; 2013; 8(7):e69643. PubMed ID: 23936062
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of radiotherapy efficacy by docetaxel-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer.
Cui FB; Li RT; Liu Q; Wu PY; Hu WJ; Yue GF; Ding H; Yu LX; Qian XP; Liu BR
Cancer Lett; 2014 Apr; 346(1):53-62. PubMed ID: 24333735
[TBL] [Abstract][Full Text] [Related]
6. Tumor delivery efficiency and apoptosis enhancement by EVO nanoparticles on murie hepatic carcinoma cell line H22.
Zhang Q; Liu Q; Shen J; Chen H; Liu B
J Biomed Nanotechnol; 2013 Aug; 9(8):1354-61. PubMed ID: 23926801
[TBL] [Abstract][Full Text] [Related]
7. Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells.
Wang Q; Yen YT; Xie C; Liu F; Liu Q; Wei J; Yu L; Wang L; Meng F; Li R; Liu B
Drug Deliv; 2021 Dec; 28(1):510-519. PubMed ID: 33657950
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex
Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E
Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331
[TBL] [Abstract][Full Text] [Related]
9. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells.
Xu S; Cui F; Huang D; Zhang D; Zhu A; Sun X; Cao Y; Ding S; Wang Y; Gao E; Zhang F
Int J Nanomedicine; 2019; 14():17-32. PubMed ID: 30587982
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery.
Zheng D; Li D; Lu X; Feng Z
Oncol Rep; 2010 Mar; 23(3):717-24. PubMed ID: 20127011
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
Jiang S; Gong X; Zhao X; Zu Y
Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
[TBL] [Abstract][Full Text] [Related]
14. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
15. Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
Wang L; Li M; Zhang N
Int J Nanomedicine; 2012; 7():3281-94. PubMed ID: 22802688
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles.
Liu Q; Li RT; Qian HQ; Wei J; Xie L; Shen J; Yang M; Qian XP; Yu LX; Jiang XQ; Liu BR
Biomaterials; 2013 Sep; 34(29):7191-203. PubMed ID: 23806972
[TBL] [Abstract][Full Text] [Related]
17. Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo.
Du XJ; Wang JL; Liu WW; Yang JX; Sun CY; Sun R; Li HJ; Shen S; Luo YL; Ye XD; Zhu YH; Yang XZ; Wang J
Biomaterials; 2015 Nov; 69():1-11. PubMed ID: 26275857
[TBL] [Abstract][Full Text] [Related]
18. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.
Lee SW; Yun MH; Jeong SW; In CH; Kim JY; Seo MH; Pai CM; Kim SO
J Control Release; 2011 Oct; 155(2):262-71. PubMed ID: 21704664
[TBL] [Abstract][Full Text] [Related]
19. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
20. A novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution.
Ma M; Hao Y; Liu N; Yin Z; Wang L; Liang X; Zhang X
Int J Nanomedicine; 2012; 7():3389-98. PubMed ID: 22848167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
